Europe Health Technology Assessment Associate Lead / Europe Health Technology Assessment Associate Lead

About the Role

As a vital member of our team, you will partner with regional access leads to anticipate the evidence needs of Health Technology Assessment (HTA) stakeholders across Europe. Your collaboration with internal cross-functional teams will involve gathering and synthesizing evidence for EU HTA-related projects, including PICO surveys and data consolidation.

You will support the development of market access strategies and clinical development plans for Takeda’s oncology portfolio, particularly focusing on evidence needs for HTA and payer stakeholders in Europe and Canada. A key responsibility includes co-leading the preparation and submission of European Union Health Technology Assessment (HTA) documents, such as Joint Clinical Assessments and Joint Scientific Consultations, ensuring compliance with EU Joint HTA guidelines and processes. Your role will also involve promoting Takeda’s values while fostering collaboration with cross-functional and global/region/local partners to enhance awareness and adoption of EU HTA evidence requirements.

How You Will Contribute

• Co-lead the strategy and development of high-quality HTA government submission dossiers for the European Union Joint Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) for new oncology medicines, working closely with the EUCAN Access Lead.
• In partnership with global and EUCAN PVA leads, ensure the timely completion of comprehensive HTA and payer evidence requirement mapping through PICO simulations for assigned assets, contributing to global development plans, statistical analysis plans, and evidence generation plans.
• As a key member of the Payer Value and Patient Access (PVPA) sub-team, represent the joint EU HTA archetype’s evidence needs in internal regional and global forums, communicating requirements and changes in joint HTA guidelines to inform global brand and asset clinical development plans.
• Collaborate closely with the EUCAN Access Lead:
  • Co-lead Joint Scientific Consultation to gather feedback on clinical trial considerations, informing clinical development and evidence generation strategies.
  • Co-lead the EU JCA submission teams, leveraging expertise and collaborating closely with regional, global, and local team members.
• Act as the single point of contact for all JCA and JSC related evidence topics for assigned priority assets, engaging with internal partners and external stakeholders, and interfacing with relevant subcommittees of the HTA Coordination Group.
• Guide internal stakeholders on the methodological requirements and specifications for EU HTA Regulation methods and procedures to complement existing product area expertise.
• Maintain up-to-date knowledge of EU HTA guidelines, methods, and processes, and effectively communicate relevant updates to internal stakeholders.
• Provide strategic insights regarding trends and relationships involving national HTA/payers and regulatory agencies (EMA) to inform EU joint HTA and reimbursement strategies.

Education, Skills, and Competencies

Required Qualifications:

• Minimum bachelor’s degree; advanced/graduate degree (MSc, PhD, MPH, MPP, MBA) preferred.
• A minimum of 6 years of experience in the biopharmaceutical industry or healthcare consulting.
• At least 4 years in market access, health economics, pricing, health policy, outcomes research, or related consulting roles, demonstrating increasing responsibility.
• Strong understanding of the EU payer and HTA environment, including HTA trends, reimbursement guidance, and technical methodologies.
• Demonstrated advanced verbal and written communication, presentation, and influencing skills – proven ability to influence without authority and work effectively within cross-functional teams.
• Ability to manage complex projects with multiple stakeholders and work well under pressure.
• Solid knowledge of drug development processes and familiarity with global pharmaceutical cross-functional teams to provide input into key deliverables.
• Proven capability to navigate ambiguity and drive discussions in complex global matrix settings to achieve optimal HTA submission outcomes.
• Expertise in framing HTA strategies and translating evidence into clear value propositions for stakeholder engagement.
• Hands-on experience with health technology assessment tools, evidence synthesis methodologies, and elicitation of clinical and HTA/payer insights.

Preferred Qualifications:

• Advanced/graduate degree (MSc, PhD, MPH, MPP, MBA).
• Degree or diploma in health economics or economic evaluations.
• Previous experience in oncology.
• Experience in regional or global roles.
• Direct experience leading national HTA submissions or scientific advice processes with HTA or regulatory agencies is a plus.

Travel Requirements

Up to 20% travel, both domestic and international, may be required.

Additional Information

• Experience in assessing evidence needs for major HTA/payer stakeholders from EU5 and/or Canada.
• Excellent collaboration and communication skills, with a proven track record in matrix environments.
• Strong internal stakeholder management skills and a solution-oriented mindset.
• Deep understanding of the clinical development process.

Apply online using the form below. Only applications matching the job profile will be considered.